Inflammatix

Inflammatix, Inc., based in Sunnyvale, California, USA, is redefining molecular diagnostics by leveraging machine learning and host-response biology to generate accurate, actionable results. Backed by leading healthcare investors and federal support, the company aims to improve outcomes and lower costs through faster, smarter testing.